Trial Profile
Long-term immunogenicity of GlaxoSmithKline's hepatitis A vaccine inactivated (HAVRIX) following administration in children in Alaska
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 24 Mar 2013
Price :
$35
*
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.